Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for dopamine in Relationship Comments (approximate match)

Showing 11 - 20 of 25 results

First page
Previous page
2
Next page
Next page

PF-219061

ZK5ZP8L5S2

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Dopamine D3 receptor

SLV-310

69GK99VB9C

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

3-((((1-METHYLETHOXY)CARBONYL)OXY)METHOXY)MORPHINAN, (9.ALPHA.,13.ALPHA.,14.ALPHA.)-

2P8DBQ9WL3

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

(18F)-PR-04.MZ

DNN9JMJ58X

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

2-PYRROLIDINEMETHANOL, .ALPHA.,.ALPHA.-DIPHENYL-, (R)-

D56JS74WW2

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Dopamine transporter

dopamine uptake

FONTURACETAM, (R)-

X4X99EKB3S

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

ETHCATHINONE

HV3BCK77BB

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (RACEMIC)

Targets:

Norepinephrine transporter

Serotonin transporter

Dopamine transporter

LEVONORDEFRIN

V008L6478D

Search for Structure

Status:

US Previously Marketed

Source:

NOV PONT W/NEOCOBEFRIN LEVONORDEFRIN by COOKE-WAITE

(1961)

Source URL:

*!

First approved in 1952

Source:

RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRIN by EASTMAN KODAK

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008592

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Adrenergic receptor alpha-2

Conditions:

Levonordefrin acts as a topical nasal decongestant and vasoconstrictor, most often used in dentistry. It is administered in a pre-mixed solution with local anesthetics, such as mepivacaine or procaine.

IOFLUPANE F-18

NT4P0L3OCX

Search for Structure

Status:

Possibly Marketed Outside US

Source:

Unknown

Source URL:

http://www.cyclotek.com/asan-medical-centre-and-duchembio-korea-licence-dat-pet-tracer-for-parkinsons-to-cyclotek/ | https://www.ncbi.nlm.nih.gov/pubmed/23160562

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Dopamine transporter

Conditions:

Parkinson's disease

18F-beta-CIT-FP is a cocaine analog with high affinity for the dopamine transporter. The compound is used as an imaging agent for PET studies and was approved in Korea to diagnose Parkinson's disease.

SODIUM-DEPENDENT DOPAMINE TRANSPORTER

F202H3PMO2

Subunit 1 (620) Similarity Search Subunit 2 (620) Similarity Search

Sequence Search

Subunit 1 (620) Similarity Search Subunit 2 (620) Similarity Search

Status:

Other

Class:

PROTEIN

Structure of PF-219061

ABSOLUTE

Structure of SLV-310

ACHIRAL

Structure of 3-((((1-METHYLETHOXY)CARBONYL)OXY)METHOXY)MORPHINAN, (9.ALPHA.,13.ALPHA.,14.ALPHA.)-

ABSOLUTE

3-((((1-METHYLETHOXY)CARBONYL)OXY)METHOXY)MORPHINAN, (9.ALPHA.,13.ALPHA.,14.ALPHA.)-

Structure of (18F)-PR-04.MZ

ABSOLUTE

Structure of 2-PYRROLIDINEMETHANOL, .ALPHA.,.ALPHA.-DIPHENYL-, (R)-

ABSOLUTE

2-PYRROLIDINEMETHANOL, .ALPHA.,.ALPHA.-DIPHENYL-, (R)-

Structure of FONTURACETAM, (R)-

ABSOLUTE

FONTURACETAM, (R)-

Structure of ETHCATHINONE

RACEMIC

Structure of LEVONORDEFRIN

ABSOLUTE

Structure of IOFLUPANE F-18

ABSOLUTE

Protein

SODIUM-DEPENDENT DOPAMINE TRANSPORTER

Showing 11 - 20 of 25 results

First page
Previous page
2
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1